Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 19, 2021
Ambulatory chemotherapy: Past, present, and futureRacha Sabbagh Dit Hawasli, Stephen Barton, Shereen Nabhani-Gebara
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Consensus Recommendations for the Safe Handling of Cytotoxic Agents in Cytotoxic Academic Research Laboratories (CARL)Shereen Nabhani Gebara, Stephen Barton, Ian Appleford, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Differential antibiotic dosing in critical care: survey on nurses' knowledge, perceptions and experienceSarah Fawaz, Stephen Barton, Laura Whitney, et al.
Drug Design, Development and Therapy|September 29, 2021
Stability of Amoxicillin and Clavulanic Acid in Separate Containers for Administration via a Y-SiteSarah Fawaz, Mahboub Merzouk, Stephen Barton, et al.
Hospital Pharmacy|June 18, 2019
Stability of Meropenem After Reconstitution for Administration by Prolonged InfusionSarah Fawaz, Stephen Barton, Laura Whitney, et al.
Drug Design, Development and Therapy|February 6, 2020
Suitability of Amoxicillin-Clavulanic Acid for Administration via Prolonged InfusionSarah Fawaz, Breanna Dixon, Stephen Barton, et al.
Expert Review of Anticancer Therapy|November 17, 2015
New investigations into the stability of Mesna using LC-MS/MS and NMRDahlia Salman, Julian Swinden, Jean-Marie R Peron, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 3, 2014
Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcomaDahlia Salman, Julian Swinden, Stephen Barton, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 30, 2009
The role of the pharmacist in optimizing the use of erythropoietin stimulating agentsShereen Nabhani Gebara, Hiba Moubayed
Pageof 9